Back to Liraglutide research

Real-world prescribing patterns and early weight and blood pressure outcomes of GLP-1-based therapies: a retrospective observational study in the United Arab Emirates.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


liraglutide semaglutide tirzepatide gip agonist glp 1 agonist glp-1r protocol relevant safety data present
Source: pubmed:41968307 · Ingested Apr 13, 2026